We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$433M
AUM Growth
+$33.6M
Cap. Flow
+$30.1M
Cap. Flow %
6.97%
Top 10 Hldgs %
35.53%
Holding
194
New
33
Increased
45
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.48M
3
PE
PARSLEY ENERGY INC
PE
+$4.25M
4
CELG
Celgene Corp
CELG
+$3.67M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.26M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$743K
2
AAPL icon
Apple
AAPL
+$533K
3
GE icon
GE Aerospace
GE
+$437K
4
GS icon
Goldman Sachs
GS
+$424K
5
MMM icon
3M
MMM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Financials 16.86%
3 Technology 16.26%
4 Energy 11.68%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PE
26
DELISTED
PARSLEY ENERGY INC
PE
$8.43M 1.95%
311,450
+171,250
+122% +$4.25M
SLB icon
27
SLB Ltd
SLB
$75B
$8.2M 1.89%
103,642
+515
+0.5% +$39.5K
CVX icon
28
Chevron
CVX
$366B
$7.85M 1.81%
74,877
+270
+0.4% +$27.2K
AIG icon
29
American International
AIG
$41.3B
$7.65M 1.77%
144,660
-13,450
-9% -$743K
AFL icon
30
Aflac
AFL
$62.6B
$7.33M 1.69%
203,168
-300
-0.1% -$10.2K
AMGN icon
31
Amgen
AMGN
$222B
$5.44M 1.26%
35,772
– –
ENOV icon
32
Enovis
ENOV
$1.53B
$4.86M 1.12%
106,788
– –
GOOG icon
33
Alphabet (Google) Class C
GOOG
$4.32T
$4.78M 1.1%
138,060
-4,340
-3% -$156K
ETN icon
34
Eaton
ETN
$174B
$4.68M 1.08%
78,350
– –
CSCO icon
35
Cisco
CSCO
$479B
$4.27M 0.99%
148,696
-2,800
-2% -$78.6K
PG icon
36
Procter & Gamble
PG
$339B
$3.91M 0.9%
46,126
-480
-1% -$39.4K
AMAT icon
37
Applied Materials
AMAT
$428B
$3.47M 0.8%
144,770
– –
GILD icon
38
Gilead Sciences
GILD
$165B
$3.29M 0.76%
39,450
+450
+1% +$39.9K
BMY icon
39
Bristol-Myers Squibb
BMY
$132B
$2.65M 0.61%
36,000
+32,000
+800% +$2.26M
MMM icon
40
3M
MMM
$94.3B
$2.47M 0.57%
16,860
-1,324
-7% -$187K
XOM icon
41
ExxonMobil
XOM
$634B
$1.97M 0.46%
21,010
– –
BBBY
42
DELISTED
Bed Bath & Beyond Inc
BBBY
$1.94M 0.45%
44,870
-725
-2% -$32.9K
FLS icon
43
Flowserve
FLS
$10.2B
$1.8M 0.42%
39,800
– –
ABBV icon
44
AbbVie
ABBV
$435B
$1.68M 0.39%
27,195
+12,035
+79% +$733K
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.52M 0.35%
29,084
– –
MCD icon
46
McDonald's
MCD
$195B
$1.29M 0.3%
10,750
– –
ALB icon
47
Albemarle
ALB
$15.5B
$1.2M 0.28%
15,183
-500
-3% -$36.7K
KO icon
48
Coca-Cola
KO
$375B
$1.05M 0.24%
23,214
-100
-0.4% -$4.52K
VZ icon
49
Verizon
VZ
$196B
$922K 0.21%
16,522
-209
-1% -$10.8K
T icon
50
AT&T
T
$163B
$881K 0.2%
26,984
+22,508
+503% +$670K
1
2
3 4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $360M AUM 19.98% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Kelly Lawrence W & Associates held 194 positions worth $433M, up 8.4% from $399M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates deployed $30.1M of net new capital in Q2 2016, opening 33 new positions and adding to 45 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was American International, an estimated $743K trimmed.

  • Kelly Lawrence W & Associates's largest Q2 2016 buy was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.
  • Kelly Lawrence W & Associates added most to Allergan plc in Q2 2016, an estimated $10.3M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2016 reduction was American International, cutting an estimated $743K.
  • Kelly Lawrence W & Associates fully exited Marsh in Q2 2016, selling an estimated $103K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $433M portfolio in Q2 2016.
  • Kelly Lawrence W & Associates opened 33 new positions and closed 6 in Q2 2016.
  • Kelly Lawrence W & Associates's portfolio value rose 8.4% quarter-over-quarter to $433M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.